QuantRx Biomedical Corporation Announces MOU Agreement With Jant Pharmacal

Published: Mar 05, 2008

DOYLESTOWN, PA--(Marketwire - March 05, 2008) - QuantRx® Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, today announced that it has entered into a Memorandum of Understanding agreement with Jant Pharmacal to form a strategic alliance to develop and commercialize new technologies and products in the areas of diagnostics and monitoring.

Back to news